Skip to main content
Premium Trial:

Request an Annual Quote

Geoff Smith, Robert Nicol

DNA Script has formed a scientific advisory board, appointing Geoff Smith to serve as chair and Robert Nicol to serve as a second board member.

Smith is an expert in genomic technologies and their applications, having spent more than 10 years working as a vice president at Solexa/Illumina where he led the development of many aspects of the core SBS sequencing chemistry, workflows and platforms, and cell-free DNA pregnancy testing portfolio. After leaving Illumina, Smith served as CEO of Cambridge Epigenetix, and he now works as an advisor to a variety of companies in the genomics space.

Nicol serves as director of the technology labs at the Broad Institute. He is also the cofounder of the MIT-Broad Foundry for Synthetic Biology. Nicol joined the Whitehead Institute/MIT Center for Genome Research in 2001, and directed the sequencing operations and technology development groups at the Broad for more than 12 years.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.